What's happening
This resolution asks the Governor to declare May 2026 as Cystic Fibrosis Awareness Month in New York.
Why it matters
Raises visibility of a rare but significant disease. With over 1,600 New Yorkers and 40,000 Americans affected by cystic fibrosis, this resolution puts a spotlight on a genetic illness that many may not fully understand, encouraging more informed public dialogue and potentially reducing stigma.
Highlights state resources and gaps in care. By acknowledging the existence of 21 specialized CF treatment centers in New York, the resolution calls attention to the state’s capacity for care, while also suggesting the ongoing need for access to innovative treatments and early diagnosis through blood screening.
Encourages action at multiple levels. By urging increased activity at the local, state, and national levels, the resolution could inspire additional advocacy, funding, and policy efforts aimed at improving quality of life, longevity, and research for those living with cystic fibrosis—impacting patients, families, and healthcare providers across New York.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Individuals and Families Affected by Cystic Fibrosis
Increased awareness can help reduce stigma, improve support networks, and potentially expand access to resources for those living with CF and their loved ones.
Cystic Fibrosis Foundation and Advocacy Organizations
These groups benefit from heightened visibility, which can drive fundraising efforts, policy initiatives, and research investments.
Healthcare Providers and CF Treatment Centers
Awareness month can lead to earlier diagnosis, better patient outcomes, and potentially more resources for clinics and specialists treating CF in New York.
Public Health Officials and Policymakers
Promoting awareness can help inform the public, guide resource allocation, and support the development of policies aimed at improving detection, treatment, and overall quality of life for people with CF.
Headline styles
Cystic Fibrosis Awareness Month
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 108
History
- Adopted
- Referred to calendar
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
Assembly Resolution No. 1379 BY: M. of A. Rules (McDonald) MEMORIALIZING Governor Kathy Hochul to proclaim May 2026, as Cystic Fibrosis Awareness Month in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official months… Show allHide
Assembly Resolution No. 1379 BY: M. of A. Rules (McDonald) MEMORIALIZING Governor Kathy Hochul to proclaim May 2026, as Cystic Fibrosis Awareness Month in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official months that are set aside to increase awareness of serious illnesses that affect the lives of citizens of New York State; and WHEREAS, Attendant to such concern, and in full accord with its long-standing traditions, this Legislative Body is justly proud to memorialize Governor Kathy Hochul to proclaim May 2026, as Cystic Fibrosis Awareness Month in the State of New York, in conjunction with the observance of National Cystic Fibrosis Month; and WHEREAS, The Cystic Fibrosis Foundation, a donor-supported nonprofit organization, is the world's leader in the search for a cure for cystic fibrosis, having raised and invested hundreds of millions of dollars to help develop drugs and therapies; and WHEREAS, The Cystic Fibrosis Foundation is working to cure cystic fibrosis and to provide all people struggling with the disease the opportunity to lead full, productive lives; and WHEREAS, Cystic fibrosis, commonly referred to as "CF", is a genetic disease affecting approximately 40,000 children and adults in the United States and more than 105,000 children and adults worldwide, over 1,600 of whom live in New York; furthermore, approximately 1,000 new cases are diagnosed each year; and WHEREAS, A defective gene causes the body to produce an abnormally thick, sticky mucus that clogs the lungs, and these secretions produce life-threatening lung infections and obstruct the pancreas, preventing digestive enzymes from reaching the intestines to help break down and absorb food; and WHEREAS, More than 10 million Americans are symptomless carriers of the defective CF gene; and WHEREAS, The median predicted age of survival for a person with CF, born in 2019, is 48.4 years; and WHEREAS, With advances in the treatment of CF, the number of adults with CF has steadily grown, and approximately 900 new cases of CF are diagnosed each year; and WHEREAS, 56% of the CF population is 18 years of age and older, and people with CF have a variety of symptoms attributed to the more than
2,000 mutations of the CF gene; and WHEREAS, Infant blood screening to detect genetic defects is the most reliable and least costly method to identify persons likely to have CF; and WHEREAS, Early diagnosis of CF permits early treatment and enhances quality… Show allHide
2,000 mutations of the CF gene; and WHEREAS, Infant blood screening to detect genetic defects is the most reliable and least costly method to identify persons likely to have CF; and WHEREAS, Early diagnosis of CF permits early treatment and enhances quality of life and longevity and the treatment of CF depends on the stage of the disease and the organs involved; and WHEREAS, Clearing mucus from the lungs is an important part of the daily CF treatment regimen, and other types of treatments include inhaled antibiotics and pancreatic enzymes, among others; and WHEREAS, There are 21 world-class treatment centers in New York which specialize in the diagnosis of CF and the care of persons with CF; and WHEREAS, A critical component of treating patients with CF includes access to innovative treatments, which can play a crucial role in the lives of patients with CF; and WHEREAS, It is imperative that there be greater public awareness of this serious disease, and more must be done to increase activity at the local, State and national levels; now, therefore, be it RESOLVED, That this Legislative Body pause in its deliberations to memorialize Governor Kathy Hochul to proclaim May 2026, as Cystic Fibrosis Awareness Month in the State of New York; and be it further RESOLVED, That a copy of this Resolution, suitably engrossed, be transmitted to The Honorable Kathy Hochul, Governor of the State of New York.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.